EGFR-mutated tumors present their most recent common ancestor (MRCA), a cell containing all the alterations that will lead to carcinogenesis, around the age of 61, which is a median of eight years before the tumor becomes clinically evident [22]. Here, EGFR is linked to neoplasm.